Stock URGN UROGEN PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features UroGen Pharma Ltd.

Equities

URGN

IL0011407140

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
13.21 USD +0.15% Intraday chart for UroGen Pharma Ltd. -0.68% -11.93%
Jun. 03 UroGen Pharma Appoints David Lin as New Chief Commercial Officer CI
May. 14 Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. URGN Stock
  4. News UroGen Pharma Ltd.
  5. MarketScreener Editorial Features